Top Markets
#1 Islamic Coin Islamic Coin +93.16%
#2 龙虾 (Lobster) 龙虾 (Lobster) +69.97%
#3 Tokenlon Tokenlon +67.84%
#4 Lisk Lisk +50.13%
#5 VeThor VeThor +25.87%
#6 Nockchain Nockchain +19.50%
#7 Collector Crypt Collector Crypt +15.40%
#8 Mubarak Mubarak +14.45%
#9 PumpMeme PumpMeme +12.92%
#10 UnifAI Network UnifAI Network +11.05%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Daiichi Sankyo Company, Limited Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited

4568
Rank in Stocks #779
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively... Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise actively involved in the research, development, manufacturing, importation, marketing, and distribution of a diverse array of medicinal products worldwide. Its extensive product lineup addresses numerous therapeutic areas. In oncology, key offerings include trastuzumab deruxtecan, an anti-HER2 antibody drug conjugate, alongside treatments like Gefitinib for malignant tumors, Bicalutamide for prostate cancer, and Tamoxifen, an anti-breast cancer agent. For pain management, the company provides mirogabalin and loxoprofen (an anti-inflammatory analgesic). Diabetes treatments feature teneligliptin/canagliflozin and teneligliptin, with colesevelam serving dual purposes for hypercholesterolemia and type 2 diabetes. Other notable prescription drugs include lacosamide (an anti-epileptic), prasugrel (an antiplatelet), denosumab (for osteoporosis and bone disorders), edoxaban (an anticoagulant), esomeprazole (for ulcer treatment), memantine (for Alzheimer's disease), and laninamivir (for influenza). The company also supplies olmesartan (an antihypertensive), levofloxacin (an antibacterial), pravastatin (for hypercholesterolemia), Silodosin (for dysuria), and ferric carboxymaltose/iron sucrose injections for anemia. Beyond prescription medications, Daiichi Sankyo markets popular consumer health brands such as Lulu (a combination cold remedy), Loxonin S (an antipyretic/anti-inflammatory painkiller), Transino (for melasma and skin improvement), Minon (skincare), and the oral care lines Breath Labo and Clean Dental. The company further contributes to public health with various vaccines, including adsorbed cell culture-derived influenza, influenza HA, measles-rubella combined, and mumps vaccines. Its operations also extend beyond human pharmaceuticals to include veterinary drugs, cosmetics, medical equipment, food products, drinking water, and the production of active pharmaceutical ingredients (APIs) and intermediates. Daiichi Sankyo is collaborating with Guardant Health on the development of Guardant360 CDx, a companion diagnostic for Enhertu, specifically for advanced metastatic non-small cell lung cancer. Founded in 1899, the company is headquartered in Tokyo, Japan.
Share Price
$17.82
Last synced: 2026-09-11
Market Cap
$32.43B
Change (1 day)
0.83%
Change (1 year)
-25.31%
Country
JP
Trade Daiichi Sankyo Company, Limited (4568)

Category

Healthcare
Operating Margin for Daiichi Sankyo Company, Limited (4568)
Operating Margin as of September 2026 TTM: 8.83%
According to Daiichi Sankyo Company, Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 8.83%. At the end of 2024 the company had an Operating Margin of 11.50%.
Operating Margin history for Daiichi Sankyo Company, Limited from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 8.83% -45.09%
2025 16.08% 39.83%
2024 11.50% 43.93%
2023 7.99% -42.85%
2022 13.98% 5.43%
2021 13.26% -53.10%
2020 28.27% 56.97%
2019 18.01% 13.34%
2018 15.89% -14.66%
2017 18.62% -29.58%
2016 26.44% 63.31%
2015 16.19% 21.64%
2014 13.31% 32.17%
2013 10.07% -3.73%
2012 10.46% -17.18%
2011 12.63% 25.92%
2010 10.03% -4.93%
2009 10.55% -40.80%
2008 17.82% 21.47%
2007 14.67% -12.21%
2006 16.71% 15.64%
2005 14.45% -9.80%
2004 16.02% 14.35%
2003 14.01% -4.63%
2002 14.69% -8.81%
2001 16.11% -33.43%
2000 24.20% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
43.92% -95.03%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
26.81% -96.96%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
29.32% -96.68%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
26.59% -96.99%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
16.65% -98.11%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.